1. Dhodapkar MV, Merlini G, Solomon A: Biology and therapy of immunoglobulin deposition diseases. Hematol Oncol Clin North Am 11:89-110, 1997.

2. Merlini G, Bellotti V: Molecular mechanisms of amyloidosis. N Engl J Med 349:583-596, 2003.

3. Bennhold H: Ein spezifishe amyloidfarbung mit kongo-root. Muenchner Medizinische 69:1537-1547, 1922.

4. Glenner G, Terry W, Harada M: Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analysis. Science 172:1150-1154, 1971.

5. Westermark P, Benson MD, Buxbaum JN: Amyloid fibril protein nomenclature. Amyloid 9:197-200, 2002.

6. Falk R, Comenzo R, Skinner M: The systemic amyloi-doses. N Engl J Med 337:898-909, 1997.

7. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356, 2002.

8. Lachmann HJ, Booth DR, Booth SE: Misdiagnosis of hereditary amyloidosis as AL amyloidosis. N Engl J Med 346:1786-1791, 2002.

9. Saraiva MJ: Transthyretin amyloidosis: a tale of weak interactions. FEBS Lett 498:201-203, 2001.

10. Drueke TB: Beta-2 microglobulin and amyloidosis. Nephrol Dial Transplant 15:17-24, 2000.

11. Merlini G, Westermark P: The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 255:159-178, 2004.

12. Kyle RA, Gertz MA: Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32:45-59, 1995.

13. Ozaki S, Abe M, Wolfenbarger D, Weiss DT, Solomon A: Preferential expression of human lambda light chain variable region subgroups in multiple myeloma, AL amyloidosis, and Waldentrom's macroglobulinemia. Clin Immunol Immunopathol 71:183-189, 1994.

14. Perfetti V, Ubbiali P, Vignarelli MC, et al.: Evidence that amyloidogenic light chains undergo antigen-driven selection. Blood 91:2948-2954, 1998.

15. Perfetti V, Casarini S, Palladini G, et al.: Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment. Blood 100:948-953, 2002.

16. Hurle MR, Helms LR, Li L, Chan W, Wetzel R: A role for destabilizing amino acid replacements in light chain amyloidosis. Proc Natl Acad Sci USA 91:5446-5450, 1994.

0 0

Post a comment